
Cramer’s Morning Take: Eli Lilly 11/24/25
Squawk on the Street
00:00
Why Lilly Wasn't Hurt Strategically
Jim Cramer explains Eli Lilly's different neuro focus and why the Novo data only briefly pressured Lilly shares.
Play episode from 01:31
Transcript


